Table 2:
Logistic regression predicting having a clinically significant cancer missed by MRI-targeted biopsy
| Univariate | Multivariate | |||||
|---|---|---|---|---|---|---|
| OR1 | 95% CI1 | p-value | OR1 | 95% CI1 | p-value | |
| Age | 0.98 | 0.94, 1.02 | 0.27 | — | — | — |
| PSA | 0.92 | 0.87, 0.97 | 0.006 | 0.95 | 0.88, 1.00 | 0.089 |
| Race | ||||||
| White | — | — | — | — | — | — |
| Black | 1.49 | 0.67, 3.11 | 0.3 | — | — | — |
| Asian | 0.49 | 0.03, 2.47 | 0.49 | — | — | — |
| Other | 1.79 | 0.09, 11.0 | 0.59 | — | — | — |
| PI-RADS score (2–5) | 0.35 | 0.21, 0.55 | <0.001 | 0.42 | 0.24, 0.70 | 0.001 |
| Volume of Prostate on MRI | 1.06 | 1.01, 1.11 | 0.023 | 1.06 | 0.99, 1.15 | 0.092 |
| Number of Targets on targeted biopsy | 0.82 | 0.71, 0.94 | 0.007 | 0.99 | 0.84, 1.15 | 0.9 |
| Prior Biopsy | 1.85 | 0.84, 4.66 | 0.15 | — | — | — |